Christopher Locher

Company: Versatope Therapeutics

Job title: Chief Executive Officer

Bio:

Christopher Locher is the CEO and a co-founder of Versatope Therapeutics, a preclinical-stage Massachusetts-based company currently focused on the development of a technology platform using nano-vesicles. He previously led drug discovery projects for infectious diseases at Vertex Pharmaceuticals in Boston, inflammatory diseases at Opsona Therapeutics in Ireland and malaria and alphaviruses vaccine development programs at Maxygen in California. He completed postdoctoral training at the University of California, San Francisco, was a Fulbright Hays Research Fellow at the Institute of Tropical Medicine in Antwerp, Belgium and received his PhD in Tropical Medicine and BA in Biological Sciences from the University of Hawai`i.

Seminars:

Advancing Exosome-Based Therapies: From Bench to Bedside 10:30 am

Overcoming current manufacturing challenges Innovating novel delivery mechanisms for enhanced efficacy Showcasing clinical trial data and future directions NEW DATA!Read more

day: Conference Day Two